![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beck Michael
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.15, Iss.3, 2010-09, pp. : 495-507
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment perspectives for the lysosomal storage diseases
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gene therapy for lysosomal storage diseases
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 10, 1998-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for ophthalmic diseases
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Prospects for the Treatment of Lysosomal Storage Diseases
Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. :